nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—Procainamide—Sunitinib—pancreatic cancer	0.428	1	CrCrCtD
Probenecid—ABCC5—Fluorouracil—pancreatic cancer	0.0471	0.106	CbGbCtD
Probenecid—ABCC6—Doxorubicin—pancreatic cancer	0.0351	0.0789	CbGbCtD
Probenecid—ABCC3—Fluorouracil—pancreatic cancer	0.0296	0.0666	CbGbCtD
Probenecid—SLC22A7—Fluorouracil—pancreatic cancer	0.0232	0.0521	CbGbCtD
Probenecid—ABCC4—Fluorouracil—pancreatic cancer	0.0227	0.0509	CbGbCtD
Probenecid—ABCC1—Epirubicin—pancreatic cancer	0.0195	0.0438	CbGbCtD
Probenecid—ABCC1—Irinotecan—pancreatic cancer	0.019	0.0426	CbGbCtD
Probenecid—ABCC2—Tamoxifen—pancreatic cancer	0.0183	0.0411	CbGbCtD
Probenecid—SLC22A7—Docetaxel—pancreatic cancer	0.0177	0.0398	CbGbCtD
Probenecid—ABCC4—Sunitinib—pancreatic cancer	0.0172	0.0387	CbGbCtD
Probenecid—ABCC3—Doxorubicin—pancreatic cancer	0.0169	0.0379	CbGbCtD
Probenecid—ABCC2—Irinotecan—pancreatic cancer	0.014	0.0315	CbGbCtD
Probenecid—ABCC1—Docetaxel—pancreatic cancer	0.0139	0.0312	CbGbCtD
Probenecid—ABCC1—Doxorubicin—pancreatic cancer	0.0104	0.0233	CbGbCtD
Probenecid—ABCC2—Docetaxel—pancreatic cancer	0.0103	0.0231	CbGbCtD
Probenecid—ABCC2—Sunitinib—pancreatic cancer	0.0102	0.023	CbGbCtD
Probenecid—ALB—Erlotinib—pancreatic cancer	0.00969	0.0218	CbGbCtD
Probenecid—CYP2C8—Tamoxifen—pancreatic cancer	0.00881	0.0198	CbGbCtD
Probenecid—ALB—Irinotecan—pancreatic cancer	0.00875	0.0197	CbGbCtD
Probenecid—ALB—Fluorouracil—pancreatic cancer	0.0084	0.0189	CbGbCtD
Probenecid—SLC10A1—bile duct—pancreatic cancer	0.00833	0.208	CbGeAlD
Probenecid—ABCC2—Doxorubicin—pancreatic cancer	0.00767	0.0172	CbGbCtD
Probenecid—CYP2C8—Erlotinib—pancreatic cancer	0.00749	0.0168	CbGbCtD
Probenecid—CYP2C19—Tamoxifen—pancreatic cancer	0.00739	0.0166	CbGbCtD
Probenecid—CYP2C8—Fluorouracil—pancreatic cancer	0.00649	0.0146	CbGbCtD
Probenecid—SLC10A1—bile—pancreatic cancer	0.0064	0.16	CbGeAlD
Probenecid—CYP2C9—Tamoxifen—pancreatic cancer	0.00614	0.0138	CbGbCtD
Probenecid—ABCB1—Tamoxifen—pancreatic cancer	0.00596	0.0134	CbGbCtD
Probenecid—ABCC3—bile duct—pancreatic cancer	0.00524	0.131	CbGeAlD
Probenecid—ABCB1—Gemcitabine—pancreatic cancer	0.00514	0.0115	CbGbCtD
Probenecid—ABCB1—Erlotinib—pancreatic cancer	0.00507	0.0114	CbGbCtD
Probenecid—ABCB1—Irinotecan—pancreatic cancer	0.00458	0.0103	CbGbCtD
Probenecid—CYP2C9—Fluorouracil—pancreatic cancer	0.00453	0.0102	CbGbCtD
Probenecid—ABCC2—bile duct—pancreatic cancer	0.00418	0.105	CbGeAlD
Probenecid—Gingival pain—Sunitinib—pancreatic cancer	0.00361	0.0901	CcSEcCtD
Probenecid—CYP3A4—Tamoxifen—pancreatic cancer	0.00357	0.00802	CbGbCtD
Probenecid—ABCB1—Docetaxel—pancreatic cancer	0.00335	0.00753	CbGbCtD
Probenecid—ABCB1—Sunitinib—pancreatic cancer	0.00334	0.0075	CbGbCtD
Probenecid—ABCC2—bile—pancreatic cancer	0.00322	0.0803	CbGeAlD
Probenecid—CYP3A4—Erlotinib—pancreatic cancer	0.00304	0.00682	CbGbCtD
Probenecid—CYP3A4—Irinotecan—pancreatic cancer	0.00274	0.00616	CbGbCtD
Probenecid—ABCB1—Doxorubicin—pancreatic cancer	0.0025	0.00562	CbGbCtD
Probenecid—PANX1—islet of Langerhans—pancreatic cancer	0.00233	0.0582	CbGeAlD
Probenecid—CYP3A4—Docetaxel—pancreatic cancer	0.00201	0.00451	CbGbCtD
Probenecid—CYP3A4—Sunitinib—pancreatic cancer	0.002	0.00449	CbGbCtD
Probenecid—SLC22A12—digestive system—pancreatic cancer	0.00185	0.0461	CbGeAlD
Probenecid—Nephrotic syndrome—Sunitinib—pancreatic cancer	0.00163	0.0407	CcSEcCtD
Probenecid—Hepatic necrosis—Tamoxifen—pancreatic cancer	0.00158	0.0395	CcSEcCtD
Probenecid—CYP3A4—Doxorubicin—pancreatic cancer	0.0015	0.00336	CbGbCtD
Probenecid—ABCC3—gall bladder—pancreatic cancer	0.00112	0.0279	CbGeAlD
Probenecid—ALB—gall bladder—pancreatic cancer	0.000953	0.0238	CbGeAlD
Probenecid—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.000732	0.0183	CcSEcCtD
Probenecid—SLC10A1—digestive system—pancreatic cancer	0.000699	0.0175	CbGeAlD
Probenecid—SLC22A11—digestive system—pancreatic cancer	0.000638	0.0159	CbGeAlD
Probenecid—SLC22A7—digestive system—pancreatic cancer	0.000623	0.0156	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.000595	0.0149	CcSEcCtD
Probenecid—SLC22A2—digestive system—pancreatic cancer	0.000554	0.0139	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.000515	0.0129	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00051	0.0127	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.000505	0.0126	CcSEcCtD
Probenecid—SLC16A1—digestive system—pancreatic cancer	0.000476	0.0119	CbGeAlD
Probenecid—ABCC3—digestive system—pancreatic cancer	0.00044	0.011	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.000437	0.0109	CcSEcCtD
Probenecid—Erythema multiforme—Tamoxifen—pancreatic cancer	0.000437	0.0109	CcSEcCtD
Probenecid—Erythema multiforme—Erlotinib—pancreatic cancer	0.000432	0.0108	CcSEcCtD
Probenecid—Flushing—Tamoxifen—pancreatic cancer	0.000429	0.0107	CcSEcCtD
Probenecid—ABCC4—pancreas—pancreatic cancer	0.000425	0.0106	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.000413	0.0103	CcSEcCtD
Probenecid—Alopecia—Tamoxifen—pancreatic cancer	0.000408	0.0102	CcSEcCtD
Probenecid—Alopecia—Erlotinib—pancreatic cancer	0.000404	0.0101	CcSEcCtD
Probenecid—SLCO1A2—digestive system—pancreatic cancer	0.000377	0.00942	CbGeAlD
Probenecid—Erythema multiforme—Sunitinib—pancreatic cancer	0.000374	0.00934	CcSEcCtD
Probenecid—Anaemia—Tamoxifen—pancreatic cancer	0.000372	0.00928	CcSEcCtD
Probenecid—Flushing—Sunitinib—pancreatic cancer	0.000367	0.00917	CcSEcCtD
Probenecid—ABCC4—digestive system—pancreatic cancer	0.000363	0.00907	CbGeAlD
Probenecid—Leukopenia—Tamoxifen—pancreatic cancer	0.00036	0.00899	CcSEcCtD
Probenecid—ABCC2—digestive system—pancreatic cancer	0.000351	0.00878	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.000351	0.00875	CcSEcCtD
Probenecid—Alopecia—Sunitinib—pancreatic cancer	0.00035	0.00873	CcSEcCtD
Probenecid—Haematuria—Gemcitabine—pancreatic cancer	0.000337	0.00842	CcSEcCtD
Probenecid—Anaemia—Sunitinib—pancreatic cancer	0.000319	0.00795	CcSEcCtD
Probenecid—Anorexia—Tamoxifen—pancreatic cancer	0.000313	0.00781	CcSEcCtD
Probenecid—Anorexia—Erlotinib—pancreatic cancer	0.00031	0.00773	CcSEcCtD
Probenecid—Leukopenia—Sunitinib—pancreatic cancer	0.000308	0.0077	CcSEcCtD
Probenecid—Flushing—Irinotecan—pancreatic cancer	0.000303	0.00755	CcSEcCtD
Probenecid—CYP2C19—digestive system—pancreatic cancer	0.000302	0.00754	CbGeAlD
Probenecid—Erythema multiforme—Gemcitabine—pancreatic cancer	0.0003	0.00749	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000293	0.00732	CcSEcCtD
Probenecid—Alopecia—Irinotecan—pancreatic cancer	0.000288	0.00719	CcSEcCtD
Probenecid—Decreased appetite—Tamoxifen—pancreatic cancer	0.000285	0.00712	CcSEcCtD
Probenecid—Aplastic anaemia—Epirubicin—pancreatic cancer	0.000284	0.00709	CcSEcCtD
Probenecid—Decreased appetite—Erlotinib—pancreatic cancer	0.000282	0.00705	CcSEcCtD
Probenecid—Pain—Tamoxifen—pancreatic cancer	0.000281	0.00701	CcSEcCtD
Probenecid—Alopecia—Gemcitabine—pancreatic cancer	0.000281	0.007	CcSEcCtD
Probenecid—Pain—Erlotinib—pancreatic cancer	0.000278	0.00693	CcSEcCtD
Probenecid—Alopecia—Fluorouracil—pancreatic cancer	0.000276	0.00689	CcSEcCtD
Probenecid—SLC22A5—digestive system—pancreatic cancer	0.000272	0.0068	CbGeAlD
Probenecid—Anorexia—Sunitinib—pancreatic cancer	0.000268	0.00669	CcSEcCtD
Probenecid—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.000263	0.00656	CcSEcCtD
Probenecid—Anaemia—Irinotecan—pancreatic cancer	0.000262	0.00655	CcSEcCtD
Probenecid—Urticaria—Tamoxifen—pancreatic cancer	0.000261	0.00651	CcSEcCtD
Probenecid—Body temperature increased—Erlotinib—pancreatic cancer	0.000257	0.00641	CcSEcCtD
Probenecid—Anaemia—Gemcitabine—pancreatic cancer	0.000256	0.00638	CcSEcCtD
Probenecid—Leukopenia—Irinotecan—pancreatic cancer	0.000254	0.00634	CcSEcCtD
Probenecid—Anaemia—Fluorouracil—pancreatic cancer	0.000251	0.00627	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000249	0.00621	CcSEcCtD
Probenecid—Leukopenia—Gemcitabine—pancreatic cancer	0.000248	0.00618	CcSEcCtD
Probenecid—Decreased appetite—Sunitinib—pancreatic cancer	0.000244	0.0061	CcSEcCtD
Probenecid—Leukopenia—Fluorouracil—pancreatic cancer	0.000243	0.00607	CcSEcCtD
Probenecid—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000242	0.00604	CcSEcCtD
Probenecid—Pain—Sunitinib—pancreatic cancer	0.000241	0.006	CcSEcCtD
Probenecid—CYP2C9—digestive system—pancreatic cancer	0.000234	0.00585	CbGeAlD
Probenecid—Pruritus—Tamoxifen—pancreatic cancer	0.000232	0.0058	CcSEcCtD
Probenecid—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000232	0.00578	CcSEcCtD
Probenecid—Pruritus—Erlotinib—pancreatic cancer	0.00023	0.00573	CcSEcCtD
Probenecid—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000226	0.00563	CcSEcCtD
Probenecid—Body temperature increased—Sunitinib—pancreatic cancer	0.000222	0.00555	CcSEcCtD
Probenecid—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000222	0.00554	CcSEcCtD
Probenecid—Anorexia—Irinotecan—pancreatic cancer	0.000221	0.00551	CcSEcCtD
Probenecid—Dizziness—Tamoxifen—pancreatic cancer	0.000217	0.00542	CcSEcCtD
Probenecid—Anorexia—Gemcitabine—pancreatic cancer	0.000215	0.00537	CcSEcCtD
Probenecid—Dizziness—Erlotinib—pancreatic cancer	0.000215	0.00536	CcSEcCtD
Probenecid—Erythema multiforme—Docetaxel—pancreatic cancer	0.000213	0.00532	CcSEcCtD
Probenecid—Anorexia—Fluorouracil—pancreatic cancer	0.000211	0.00528	CcSEcCtD
Probenecid—ABCB1—islet of Langerhans—pancreatic cancer	0.00021	0.00526	CbGeAlD
Probenecid—Flushing—Docetaxel—pancreatic cancer	0.000209	0.00522	CcSEcCtD
Probenecid—Vomiting—Tamoxifen—pancreatic cancer	0.000209	0.00521	CcSEcCtD
Probenecid—Hypersensitivity—Sunitinib—pancreatic cancer	0.000207	0.00517	CcSEcCtD
Probenecid—Dermatitis—Tamoxifen—pancreatic cancer	0.000207	0.00516	CcSEcCtD
Probenecid—Vomiting—Erlotinib—pancreatic cancer	0.000207	0.00515	CcSEcCtD
Probenecid—Headache—Tamoxifen—pancreatic cancer	0.000206	0.00513	CcSEcCtD
Probenecid—Dermatitis—Erlotinib—pancreatic cancer	0.000205	0.00511	CcSEcCtD
Probenecid—Headache—Erlotinib—pancreatic cancer	0.000204	0.00508	CcSEcCtD
Probenecid—Decreased appetite—Irinotecan—pancreatic cancer	0.000201	0.00502	CcSEcCtD
Probenecid—Alopecia—Docetaxel—pancreatic cancer	0.000199	0.00497	CcSEcCtD
Probenecid—Pruritus—Sunitinib—pancreatic cancer	0.000199	0.00496	CcSEcCtD
Probenecid—Pain—Irinotecan—pancreatic cancer	0.000198	0.00494	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000198	0.00494	CcSEcCtD
Probenecid—Decreased appetite—Gemcitabine—pancreatic cancer	0.000196	0.00489	CcSEcCtD
Probenecid—Nausea—Tamoxifen—pancreatic cancer	0.000195	0.00487	CcSEcCtD
Probenecid—Pain—Gemcitabine—pancreatic cancer	0.000193	0.00481	CcSEcCtD
Probenecid—Nausea—Erlotinib—pancreatic cancer	0.000193	0.00481	CcSEcCtD
Probenecid—Decreased appetite—Fluorouracil—pancreatic cancer	0.000193	0.00481	CcSEcCtD
Probenecid—Pain—Fluorouracil—pancreatic cancer	0.00019	0.00473	CcSEcCtD
Probenecid—Dizziness—Sunitinib—pancreatic cancer	0.000186	0.00464	CcSEcCtD
Probenecid—Body temperature increased—Irinotecan—pancreatic cancer	0.000183	0.00457	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000183	0.00457	CcSEcCtD
Probenecid—Anaemia—Docetaxel—pancreatic cancer	0.000181	0.00453	CcSEcCtD
Probenecid—Vomiting—Sunitinib—pancreatic cancer	0.000179	0.00446	CcSEcCtD
Probenecid—CYP3A4—digestive system—pancreatic cancer	0.000178	0.00446	CbGeAlD
Probenecid—Body temperature increased—Gemcitabine—pancreatic cancer	0.000178	0.00445	CcSEcCtD
Probenecid—Dermatitis—Sunitinib—pancreatic cancer	0.000177	0.00442	CcSEcCtD
Probenecid—Urticaria—Fluorouracil—pancreatic cancer	0.000176	0.0044	CcSEcCtD
Probenecid—Headache—Sunitinib—pancreatic cancer	0.000176	0.0044	CcSEcCtD
Probenecid—Leukopenia—Docetaxel—pancreatic cancer	0.000176	0.00438	CcSEcCtD
Probenecid—Pollakiuria—Epirubicin—pancreatic cancer	0.000175	0.00438	CcSEcCtD
Probenecid—Body temperature increased—Fluorouracil—pancreatic cancer	0.000175	0.00438	CcSEcCtD
Probenecid—Hypersensitivity—Irinotecan—pancreatic cancer	0.000171	0.00426	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000168	0.00419	CcSEcCtD
Probenecid—Nausea—Sunitinib—pancreatic cancer	0.000167	0.00417	CcSEcCtD
Probenecid—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000163	0.00408	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—pancreatic cancer	0.000162	0.00405	CcSEcCtD
Probenecid—Haematuria—Epirubicin—pancreatic cancer	0.000161	0.00403	CcSEcCtD
Probenecid—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00016	0.004	CcSEcCtD
Probenecid—Pruritus—Gemcitabine—pancreatic cancer	0.00016	0.00398	CcSEcCtD
Probenecid—Pruritus—Fluorouracil—pancreatic cancer	0.000157	0.00392	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000155	0.00388	CcSEcCtD
Probenecid—Dizziness—Irinotecan—pancreatic cancer	0.000153	0.00382	CcSEcCtD
Probenecid—Anorexia—Docetaxel—pancreatic cancer	0.000153	0.00381	CcSEcCtD
Probenecid—Haematuria—Doxorubicin—pancreatic cancer	0.000149	0.00373	CcSEcCtD
Probenecid—ABCB1—pancreas—pancreatic cancer	0.000148	0.0037	CbGeAlD
Probenecid—Vomiting—Irinotecan—pancreatic cancer	0.000147	0.00368	CcSEcCtD
Probenecid—Dizziness—Fluorouracil—pancreatic cancer	0.000147	0.00366	CcSEcCtD
Probenecid—Dermatitis—Irinotecan—pancreatic cancer	0.000146	0.00364	CcSEcCtD
Probenecid—Headache—Irinotecan—pancreatic cancer	0.000145	0.00362	CcSEcCtD
Probenecid—Erythema multiforme—Epirubicin—pancreatic cancer	0.000144	0.00359	CcSEcCtD
Probenecid—Vomiting—Gemcitabine—pancreatic cancer	0.000143	0.00358	CcSEcCtD
Probenecid—Dermatitis—Gemcitabine—pancreatic cancer	0.000142	0.00355	CcSEcCtD
Probenecid—Headache—Gemcitabine—pancreatic cancer	0.000141	0.00353	CcSEcCtD
Probenecid—Flushing—Epirubicin—pancreatic cancer	0.000141	0.00352	CcSEcCtD
Probenecid—Vomiting—Fluorouracil—pancreatic cancer	0.000141	0.00352	CcSEcCtD
Probenecid—Dermatitis—Fluorouracil—pancreatic cancer	0.00014	0.00349	CcSEcCtD
Probenecid—Decreased appetite—Docetaxel—pancreatic cancer	0.000139	0.00347	CcSEcCtD
Probenecid—Headache—Fluorouracil—pancreatic cancer	0.000139	0.00347	CcSEcCtD
Probenecid—Nausea—Irinotecan—pancreatic cancer	0.000138	0.00343	CcSEcCtD
Probenecid—Pain—Docetaxel—pancreatic cancer	0.000137	0.00342	CcSEcCtD
Probenecid—Alopecia—Epirubicin—pancreatic cancer	0.000134	0.00335	CcSEcCtD
Probenecid—Nausea—Gemcitabine—pancreatic cancer	0.000134	0.00334	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000133	0.00332	CcSEcCtD
Probenecid—Nausea—Fluorouracil—pancreatic cancer	0.000132	0.00329	CcSEcCtD
Probenecid—Flushing—Doxorubicin—pancreatic cancer	0.000131	0.00326	CcSEcCtD
Probenecid—Body temperature increased—Docetaxel—pancreatic cancer	0.000127	0.00316	CcSEcCtD
Probenecid—ABCB1—digestive system—pancreatic cancer	0.000126	0.00316	CbGeAlD
Probenecid—Alopecia—Doxorubicin—pancreatic cancer	0.000124	0.0031	CcSEcCtD
Probenecid—Anaemia—Epirubicin—pancreatic cancer	0.000122	0.00305	CcSEcCtD
Probenecid—Leukopenia—Epirubicin—pancreatic cancer	0.000118	0.00296	CcSEcCtD
Probenecid—Hypersensitivity—Docetaxel—pancreatic cancer	0.000118	0.00294	CcSEcCtD
Probenecid—Pruritus—Docetaxel—pancreatic cancer	0.000113	0.00283	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—pancreatic cancer	0.000113	0.00282	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—pancreatic cancer	0.00011	0.00274	CcSEcCtD
Probenecid—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000108	0.0027	CcSEcCtD
Probenecid—Dizziness—Docetaxel—pancreatic cancer	0.000106	0.00264	CcSEcCtD
Probenecid—Anorexia—Epirubicin—pancreatic cancer	0.000103	0.00257	CcSEcCtD
Probenecid—Vomiting—Docetaxel—pancreatic cancer	0.000102	0.00254	CcSEcCtD
Probenecid—Dermatitis—Docetaxel—pancreatic cancer	0.000101	0.00252	CcSEcCtD
Probenecid—Headache—Docetaxel—pancreatic cancer	0.0001	0.0025	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—pancreatic cancer	9.99e-05	0.00249	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—pancreatic cancer	9.53e-05	0.00238	CcSEcCtD
Probenecid—Nausea—Docetaxel—pancreatic cancer	9.51e-05	0.00237	CcSEcCtD
Probenecid—Decreased appetite—Epirubicin—pancreatic cancer	9.39e-05	0.00234	CcSEcCtD
Probenecid—Pain—Epirubicin—pancreatic cancer	9.24e-05	0.0023	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—pancreatic cancer	8.69e-05	0.00217	CcSEcCtD
Probenecid—Urticaria—Epirubicin—pancreatic cancer	8.58e-05	0.00214	CcSEcCtD
Probenecid—Pain—Doxorubicin—pancreatic cancer	8.55e-05	0.00213	CcSEcCtD
Probenecid—Body temperature increased—Epirubicin—pancreatic cancer	8.54e-05	0.00213	CcSEcCtD
Probenecid—Hypersensitivity—Epirubicin—pancreatic cancer	7.96e-05	0.00199	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—pancreatic cancer	7.94e-05	0.00198	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—pancreatic cancer	7.9e-05	0.00197	CcSEcCtD
Probenecid—Pruritus—Epirubicin—pancreatic cancer	7.64e-05	0.00191	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—pancreatic cancer	7.36e-05	0.00184	CcSEcCtD
Probenecid—Dizziness—Epirubicin—pancreatic cancer	7.14e-05	0.00178	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—pancreatic cancer	7.07e-05	0.00176	CcSEcCtD
Probenecid—Vomiting—Epirubicin—pancreatic cancer	6.87e-05	0.00171	CcSEcCtD
Probenecid—Dermatitis—Epirubicin—pancreatic cancer	6.8e-05	0.0017	CcSEcCtD
Probenecid—Headache—Epirubicin—pancreatic cancer	6.77e-05	0.00169	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—pancreatic cancer	6.61e-05	0.00165	CcSEcCtD
Probenecid—Nausea—Epirubicin—pancreatic cancer	6.42e-05	0.0016	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—pancreatic cancer	6.35e-05	0.00159	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—pancreatic cancer	6.3e-05	0.00157	CcSEcCtD
Probenecid—Headache—Doxorubicin—pancreatic cancer	6.26e-05	0.00156	CcSEcCtD
Probenecid—Nausea—Doxorubicin—pancreatic cancer	5.94e-05	0.00148	CcSEcCtD
Probenecid—ABCC5—Disease—PTEN—pancreatic cancer	6.62e-06	0.000142	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GCG—pancreatic cancer	6.61e-06	0.000142	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—TYMS—pancreatic cancer	6.59e-06	0.000141	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.57e-06	0.000141	CbGpPWpGaD
Probenecid—ABCC1—Disease—HIF1A—pancreatic cancer	6.56e-06	0.00014	CbGpPWpGaD
Probenecid—ABCC1—Disease—TSC2—pancreatic cancer	6.54e-06	0.00014	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.53e-06	0.00014	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TYMP—pancreatic cancer	6.48e-06	0.000139	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CG—pancreatic cancer	6.48e-06	0.000139	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.47e-06	0.000139	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—pancreatic cancer	6.47e-06	0.000139	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GLP1R—pancreatic cancer	6.42e-06	0.000138	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CB—pancreatic cancer	6.42e-06	0.000137	CbGpPWpGaD
Probenecid—ALB—Hemostasis—EGF—pancreatic cancer	6.4e-06	0.000137	CbGpPWpGaD
Probenecid—ABCC1—Disease—APOE—pancreatic cancer	6.4e-06	0.000137	CbGpPWpGaD
Probenecid—ALB—Metabolism—GLP1R—pancreatic cancer	6.38e-06	0.000137	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTGS2—pancreatic cancer	6.36e-06	0.000136	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	6.34e-06	0.000136	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—DPYD—pancreatic cancer	6.31e-06	0.000135	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	6.29e-06	0.000135	CbGpPWpGaD
Probenecid—ALB—Metabolism—DPYD—pancreatic cancer	6.28e-06	0.000135	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—STK11—pancreatic cancer	6.22e-06	0.000133	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—HRAS—pancreatic cancer	6.19e-06	0.000133	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CG—pancreatic cancer	6.17e-06	0.000132	CbGpPWpGaD
Probenecid—ABCC5—Disease—SRC—pancreatic cancer	6.14e-06	0.000132	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	5.99e-06	0.000128	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CB—pancreatic cancer	5.96e-06	0.000128	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC2A2—pancreatic cancer	5.96e-06	0.000128	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PPARG—pancreatic cancer	5.96e-06	0.000128	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—APOE—pancreatic cancer	5.96e-06	0.000128	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.93e-06	0.000127	CbGpPWpGaD
Probenecid—ABCC5—Disease—STAT3—pancreatic cancer	5.92e-06	0.000127	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTGS2—pancreatic cancer	5.91e-06	0.000127	CbGpPWpGaD
Probenecid—ABCC5—Disease—NRAS—pancreatic cancer	5.91e-06	0.000127	CbGpPWpGaD
Probenecid—ABCC1—Disease—NOTCH1—pancreatic cancer	5.91e-06	0.000127	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.9e-06	0.000126	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	5.87e-06	0.000126	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.87e-06	0.000126	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	5.78e-06	0.000124	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—TYMS—pancreatic cancer	5.74e-06	0.000123	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GLP1R—pancreatic cancer	5.73e-06	0.000123	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.72e-06	0.000123	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGF—pancreatic cancer	5.71e-06	0.000122	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CD—pancreatic cancer	5.69e-06	0.000122	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.69e-06	0.000122	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PRSS1—pancreatic cancer	5.64e-06	0.000121	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.64e-06	0.000121	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—DPYD—pancreatic cancer	5.64e-06	0.000121	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GLP1R—pancreatic cancer	5.59e-06	0.00012	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.59e-06	0.00012	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTEN—pancreatic cancer	5.54e-06	0.000119	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—DPYD—pancreatic cancer	5.5e-06	0.000118	CbGpPWpGaD
Probenecid—ABCC5—Disease—MYC—pancreatic cancer	5.5e-06	0.000118	CbGpPWpGaD
Probenecid—ABCC5—Disease—TGFB1—pancreatic cancer	5.49e-06	0.000118	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—AKT1—pancreatic cancer	5.46e-06	0.000117	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CD—pancreatic cancer	5.43e-06	0.000116	CbGpPWpGaD
Probenecid—ABCC5—Disease—EGFR—pancreatic cancer	5.38e-06	0.000115	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	5.37e-06	0.000115	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—APOE—pancreatic cancer	5.36e-06	0.000115	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	5.35e-06	0.000115	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—TYMS—pancreatic cancer	5.35e-06	0.000115	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.35e-06	0.000115	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.29e-06	0.000113	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GLP1R—pancreatic cancer	5.22e-06	0.000112	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC2A2—pancreatic cancer	5.22e-06	0.000112	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.21e-06	0.000112	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PPARG—pancreatic cancer	5.19e-06	0.000111	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.18e-06	0.000111	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTEN—pancreatic cancer	5.15e-06	0.00011	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—DPYD—pancreatic cancer	5.14e-06	0.00011	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.11e-06	0.000109	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PIK3CA—pancreatic cancer	5.1e-06	0.000109	CbGpPWpGaD
Probenecid—ABCC5—Disease—KRAS—pancreatic cancer	5.08e-06	0.000109	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CD—pancreatic cancer	5.08e-06	0.000109	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.07e-06	0.000109	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CB—pancreatic cancer	4.96e-06	0.000106	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.89e-06	0.000105	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	4.88e-06	0.000104	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CG—pancreatic cancer	4.84e-06	0.000104	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.83e-06	0.000103	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	4.79e-06	0.000103	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CB—pancreatic cancer	4.73e-06	0.000101	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	4.73e-06	0.000101	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.72e-06	0.000101	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTGS2—pancreatic cancer	4.69e-06	0.0001	CbGpPWpGaD
Probenecid—ABCC5—Disease—PIK3CA—pancreatic cancer	4.67e-06	0.0001	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PPARG—pancreatic cancer	4.67e-06	0.0001	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—APOE—pancreatic cancer	4.67e-06	0.0001	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.66e-06	9.98e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.65e-06	9.97e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CD44—pancreatic cancer	4.64e-06	9.94e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CD44—pancreatic cancer	4.61e-06	9.88e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.54e-06	9.73e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.52e-06	9.68e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.5e-06	9.65e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.48e-06	9.59e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GCG—pancreatic cancer	4.45e-06	9.53e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CB—pancreatic cancer	4.43e-06	9.48e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GCG—pancreatic cancer	4.42e-06	9.48e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTGS2—pancreatic cancer	4.38e-06	9.39e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—APOE—pancreatic cancer	4.35e-06	9.32e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—HRAS—pancreatic cancer	4.32e-06	9.26e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.27e-06	9.16e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CD—pancreatic cancer	4.25e-06	9.11e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.24e-06	9.09e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	4.21e-06	9.02e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—STK11—pancreatic cancer	4.18e-06	8.96e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—pancreatic cancer	4.17e-06	8.93e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—STK11—pancreatic cancer	4.16e-06	8.91e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CD44—pancreatic cancer	4.14e-06	8.87e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	4.12e-06	8.82e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTEN—pancreatic cancer	4.09e-06	8.76e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	4.08e-06	8.74e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PPARG—pancreatic cancer	4.07e-06	8.71e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.06e-06	8.69e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CD44—pancreatic cancer	4.04e-06	8.66e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.02e-06	8.61e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—SRC—pancreatic cancer	3.98e-06	8.52e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GCG—pancreatic cancer	3.97e-06	8.51e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.93e-06	8.41e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	3.93e-06	8.41e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CTNNB1—pancreatic cancer	3.92e-06	8.4e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CA—pancreatic cancer	3.91e-06	8.38e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.9e-06	8.36e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GCG—pancreatic cancer	3.88e-06	8.3e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—pancreatic cancer	3.87e-06	8.3e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NRAS—pancreatic cancer	3.83e-06	8.2e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—pancreatic cancer	3.82e-06	8.19e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—pancreatic cancer	3.81e-06	8.17e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PPARG—pancreatic cancer	3.79e-06	8.12e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CD44—pancreatic cancer	3.78e-06	8.09e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—STK11—pancreatic cancer	3.73e-06	8e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CB—pancreatic cancer	3.71e-06	7.94e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	3.7e-06	7.93e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.7e-06	7.92e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—pancreatic cancer	3.67e-06	7.87e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.66e-06	7.85e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—STK11—pancreatic cancer	3.64e-06	7.81e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—pancreatic cancer	3.64e-06	7.79e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GCG—pancreatic cancer	3.62e-06	7.76e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—TYMS—pancreatic cancer	3.6e-06	7.71e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—TYMS—pancreatic cancer	3.58e-06	7.66e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—pancreatic cancer	3.56e-06	7.62e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TGFB1—pancreatic cancer	3.56e-06	7.62e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—SRC—pancreatic cancer	3.55e-06	7.6e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.5e-06	7.51e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	3.45e-06	7.39e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.45e-06	7.38e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—pancreatic cancer	3.42e-06	7.33e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—NRAS—pancreatic cancer	3.41e-06	7.31e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—STK11—pancreatic cancer	3.4e-06	7.29e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.39e-06	7.26e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—pancreatic cancer	3.29e-06	7.05e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	3.23e-06	6.91e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.22e-06	6.89e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—TYMS—pancreatic cancer	3.21e-06	6.88e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—pancreatic cancer	3.2e-06	6.86e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—pancreatic cancer	3.2e-06	6.85e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.2e-06	6.85e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—pancreatic cancer	3.19e-06	6.84e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—pancreatic cancer	3.18e-06	6.81e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TGFB1—pancreatic cancer	3.17e-06	6.79e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TYMS—pancreatic cancer	3.13e-06	6.72e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—pancreatic cancer	3.11e-06	6.66e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—pancreatic cancer	3.03e-06	6.48e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	3.01e-06	6.44e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—pancreatic cancer	2.98e-06	6.38e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—pancreatic cancer	2.97e-06	6.36e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—pancreatic cancer	2.94e-06	6.29e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TYMS—pancreatic cancer	2.93e-06	6.27e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—pancreatic cancer	2.93e-06	6.27e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOE—pancreatic cancer	2.93e-06	6.27e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOE—pancreatic cancer	2.91e-06	6.23e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—pancreatic cancer	2.88e-06	6.18e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HRAS—pancreatic cancer	2.8e-06	6e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—pancreatic cancer	2.79e-06	5.97e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.77e-06	5.93e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.75e-06	5.9e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—pancreatic cancer	2.7e-06	5.78e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.64e-06	5.66e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CG—pancreatic cancer	2.63e-06	5.63e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOE—pancreatic cancer	2.61e-06	5.6e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—pancreatic cancer	2.6e-06	5.57e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOE—pancreatic cancer	2.55e-06	5.46e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.55e-06	5.46e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARG—pancreatic cancer	2.53e-06	5.43e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	2.51e-06	5.38e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—HRAS—pancreatic cancer	2.5e-06	5.35e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CD44—pancreatic cancer	2.49e-06	5.34e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.47e-06	5.3e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—pancreatic cancer	2.47e-06	5.29e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GCG—pancreatic cancer	2.39e-06	5.12e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOE—pancreatic cancer	2.38e-06	5.1e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.36e-06	5.05e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—pancreatic cancer	2.36e-06	5.05e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.32e-06	4.97e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CD—pancreatic cancer	2.31e-06	4.95e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.3e-06	4.93e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.28e-06	4.87e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—pancreatic cancer	2.26e-06	4.84e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.25e-06	4.83e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—STK11—pancreatic cancer	2.25e-06	4.81e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARG—pancreatic cancer	2.22e-06	4.76e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—pancreatic cancer	2.2e-06	4.72e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.15e-06	4.6e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.07e-06	4.44e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.07e-06	4.44e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—pancreatic cancer	2.05e-06	4.39e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.02e-06	4.34e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.02e-06	4.33e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CB—pancreatic cancer	2.01e-06	4.31e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.01e-06	4.3e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—pancreatic cancer	1.99e-06	4.27e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	1.97e-06	4.21e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.93e-06	4.14e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.89e-06	4.05e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—pancreatic cancer	1.85e-06	3.95e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	1.83e-06	3.93e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.81e-06	3.87e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.79e-06	3.83e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.76e-06	3.78e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.75e-06	3.75e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.75e-06	3.74e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—pancreatic cancer	1.74e-06	3.72e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.65e-06	3.53e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.63e-06	3.5e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—pancreatic cancer	1.61e-06	3.44e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOE—pancreatic cancer	1.57e-06	3.36e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.56e-06	3.34e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—pancreatic cancer	1.52e-06	3.26e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—pancreatic cancer	1.5e-06	3.21e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.42e-06	3.05e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.42e-06	3.04e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.37e-06	2.93e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.25e-06	2.67e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.23e-06	2.64e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—pancreatic cancer	1.23e-06	2.63e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.1e-06	2.36e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.09e-06	2.33e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.08e-06	2.31e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.07e-06	2.3e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.01e-06	2.16e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1e-06	2.15e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—pancreatic cancer	1e-06	2.15e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—pancreatic cancer	9.39e-07	2.01e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—pancreatic cancer	9e-07	1.93e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—pancreatic cancer	8.78e-07	1.88e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—pancreatic cancer	8.2e-07	1.76e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.62e-07	1.42e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.41e-07	1.16e-05	CbGpPWpGaD
